Cellular factors regulate transactivation of human immunodeficiency virus type 1

Area of Science:

• Molecular Virology
• Gene Regulation
• Retroviral Studies

Background:

• Immediate-early (IE) gene products of human cytomegalovirus (CMV) and the transactivator (TAT) of human immunodeficiency virus type 1 (HIV-1) are key regulators of viral gene expression.
• Understanding the mechanisms by which these viral proteins interact with host cell factors to modulate viral gene expression is crucial for developing therapeutic strategies.

Purpose of the Study:

• To investigate the transactivation of the HIV-1 long terminal repeat (LTR) by CMV IE gene products and HIV-1 TAT.
• To determine the role of host cell factors in differential transactivation activities observed between cell types.

Main Methods:

• Transient transfection assays utilizing chloramphenicol acetyltransferase (CAT) reporter gene under the control of the HIV-1 LTR.
• Expression plasmids for HIV-1 TAT and human CMV IE were co-transfected into various cell types.
• Analysis of RNA species initiated at the HIV-1 LTR to assess transcriptional elongation.

Main Results:

• The ratio of transactivation by CMV IE compared to HIV-1 TAT varied significantly (up to 1,000-fold) across different cell types.
• Differential transactivator gene expression did not account for the observed variations in activity.
• Evidence suggests that cellular factors regulate the elongation step of transcription from the HIV-1 LTR.

Conclusions:

• Host cell factors play a critical role in modulating the activity of viral transactivators, including CMV IE and HIV-1 TAT.
• The mechanisms of HIV-1 TAT-mediated transactivation can involve post-transcriptional processes in certain cell types.
• These findings highlight the complex interplay between viral proteins and host cell machinery in regulating HIV-1 gene expression.